Rest Of Europe Single Cell Sequencing Market (2025-2030)
The Rest Of Europe Single Cell Sequencing Market was valued at $102.5 Million in 2025 and projected to reach to $174.3 Million by 2030, representing a compound annual growth rate of 11.2%. Rest Of Europe's single cell sequencing market is poised for sustained expansion through 2030, driven by increasing adoption across academic research centers, clinical diagnostics, and pharmaceutical development.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe Single Cell Sequencing Market Trends and Insights
- This 11.2% compound annual growth rate reflects increasing adoption of advanced genomic technologies across research institutions, clinical laboratories, and pharmaceutical companies throughout the region.
- Rest Of Europe is benefiting from rising investments in precision medicine, growing prevalence of chronic diseases, and expanding research collaborations that drive demand for single cell analysis capabilities. The market in Rest Of Europe is characterized by strong regulatory support and a well-established healthcare infrastructure that facilitates technology adoption.
- Rest Of Europe's research community is increasingly leveraging single cell sequencing for immunology, oncology, and developmental biology applications.
- Between 2025 and 2030, Rest Of Europe is expected to see accelerated growth driven by declining sequencing costs, improved accessibility to platforms, and heightened focus on personalized therapeutic development across multiple therapeutic areas..
Key Market Statistics
- CAGR (2025-2030) 11.2% CAGR
- Market Size, 2025 ~USD 102.5 Million
- Forecast, 2030 ~USD 174.3 Million
- Country Rest Of Europe
Rest Of Europe Single Cell Sequencing Market Overview
Market Valuation Growth :
Rest Of Europe's single cell sequencing market is valued at $102.5 million in 2025, with projections reaching $174.3 million by 2030, representing a strong 11.2% CAGR driven by technological advancement and increased research funding.
Regional Research Infrastructure :
The region benefits from well-established research institutions and clinical laboratories across multiple countries, fostering collaborative genomic research initiatives and accelerating adoption of single cell sequencing technologies.
Pharmaceutical & Biotech Expansion :
Pharmaceutical companies and biotech firms throughout Rest Of Europe are increasingly integrating single cell sequencing into drug discovery and development pipelines, supporting market expansion beyond traditional research applications.
Competitive CAGR Performance :
With an 11.2% CAGR, Rest Of Europe demonstrates solid growth momentum, though slightly below the global average of 12.2%, indicating emerging market maturation and increasing regional investment in genomic technologies.
Rest Of Europe Single Cell Sequencing Market Dynamics
- The region's strong scientific infrastructure and collaborative research networks are facilitating technology integration and skill development among life science professionals. Key growth catalysts include rising government funding for genomic research, growing prevalence of precision medicine initiatives, and expanding applications in oncology and immunology research.
- As sequencing costs decline and instrument accessibility improves, smaller research institutions and clinical laboratories throughout Rest Of Europe are expected to adopt these technologies, further broadening the market base and supporting the projected 11.2% CAGR through 2030..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Rest Of Europe's single cell sequencing market will grow from $102.5M (2025) to $174.3M (2030) at an 11.2% CAGR.
- Rest Of Europe is experiencing increased adoption of single cell technologies in precision medicine and immunotherapy research.
- Rest Of Europe benefits from strong regulatory frameworks and collaborative research networks supporting market expansion.
- Rest Of Europe's declining sequencing costs and improved platform accessibility are key drivers of market growth through 2030.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
Rest Of Europe Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
Target Audience
- Pharmaceutical & Biotech Companies : Need regional market data to assess single cell sequencing adoption in drug discovery pipelines, identify collaboration opportunities with European research institutions, and plan R&D investments across Rest Of Europe.
- Sequencing Equipment Manufacturers : Require market sizing and growth forecasts specific to Rest Of Europe to develop regional sales strategies, identify high-potential customer segments, and allocate resources for market penetration and customer support.
- Clinical Laboratory Operators : Need insights into regional adoption trends, reimbursement landscapes, and competitive positioning to evaluate single cell sequencing integration into diagnostic offerings and justify capital investments.
- Research Institutions & Universities : Seek market intelligence on funding trends, technology adoption patterns, and collaborative opportunities within Rest Of Europe's research community to inform strategic planning and grant applications.
- Healthcare Investors & Consultants : Require comprehensive regional market analysis to evaluate investment opportunities, assess growth potential, and provide strategic guidance to clients operating in Rest Of Europe's genomic sequencing sector.
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise valuation data specific to Rest Of Europe ($102.5M in 2025, $174.3M in 2030) with country-level breakdowns, enabling accurate budget allocation and market entry strategies tailored to regional dynamics.
- Competitive Landscape Analysis : Understand key players, market share distribution, and competitive positioning within Rest Of Europe's single cell sequencing ecosystem to identify partnership opportunities and differentiation strategies.
- Growth Driver Identification : Analyze region-specific factors driving the 11.2% CAGR, including research funding trends, regulatory environment, and technology adoption patterns unique to Rest Of Europe's scientific community.
- End-User Demand Insights : Gain detailed understanding of demand from academic institutions, clinical laboratories, and pharmaceutical companies across Rest Of Europe to optimize product development and go-to-market strategies.
- Investment & Expansion Planning : Support strategic decision-making for market entry, facility expansion, or partnership development in Rest Of Europe with comprehensive market intelligence and growth opportunity assessment.
Frequently asked questions
What is the market size of single cell sequencing in Rest Of Europe in 2025?
Rest Of Europe's single cell sequencing market is valued at $102.5 million in 2025.
What is the projected market size for Rest Of Europe by 2030?
Rest Of Europe's single cell sequencing market is forecast to reach $174.3 million by 2030.
What is the CAGR for Rest Of Europe's single cell sequencing market?
Rest Of Europe's single cell sequencing market is expected to grow at a compound annual growth rate of 11.2% from 2025 to 2030.
What are the primary drivers of growth in Rest Of Europe's market?
Rest Of Europe's market growth is driven by increased precision medicine investments, declining sequencing costs, expanding research collaborations, and rising adoption in oncology and immunology applications.
Which applications are most prevalent in Rest Of Europe's single cell sequencing market?
Rest Of Europe's research community primarily uses single cell sequencing for immunology, oncology, developmental biology, and personalized therapeutic development applications.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
